The vast majority of microbiome studies failed to address core methodological aspects including the use of anaerobic conditions, sample volume, storage etc. with a lack of protocol normalization and standardization (1). Following the agreement [...]
Our new research article: “GutAlive® enables DNA-based microbiome analysis without disrupting the original composition and diversity” A precise faecal microbiome analysis requires normalized methods for microbiome sampling, transport and manipulation in order to obtain [...]
Microviable Therapeutics will be presenting at XIV Workshop of SEMiPYP (Spanish Society of Microbiota, Probiotics and Prebiotics) taking place on March 8th-10th at Pamplona. Claudio Hidalgo, CEO at Microviable, Noelia Martínez, R&D Director, and Ignacio [...]
Checkout our new GutAlive® !! The unique user-friendly, high-capacity device for stool collection sampling and transport in anaerobic conditions that ensures sample stability, microbiota viability and preserves DNA integrity. GutAlive® preserves the [...]